Tevogen Bio Holdings is actively advancing its strategic acquisition plan.

This series of measures is expected to bring the company a combined annual revenue potential of approximately 100 million US dollars. The strategy aims to expand the business landscape and strengthen market competitiveness through acquisition integration. Company management stated that the relevant plans are being steadily implemented, and further specific progress will be disclosed in the future.